Literature DB >> 6874949

Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy.

R A Knazek, W B Rizzo, J D Schulman, J R Dave.   

Abstract

Adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN) are related X-linked disorders characterized by adrenal, gonadal, and nervous system dysfunction. While the pathologic finding common to these tissues appears to be the accumulation of excessive amounts of very long chain fatty acids, the mechanism leading to functional impairment in these tissues is unclear. Measurements of fluorescence polarization (P), using the lipid probe diphenylhexatriene, demonstrate a highly significant increase in the microviscosity of erythrocyte membranes in affected patients (P = 0.286 +/- 0.012) vs. normals (P = 0.239 +/- 0.020). Analyses of these membranes by gas-liquid chromatography revealed 1.9-, 1.6-, and 1.3-fold increases above normal values in the C25:0, C26:0, and C27:0 fatty acids, respectively. These observations are compatible with previously obtained data in animals that correlate membrane microviscosity with the number of hormone receptors in target tissues. The present data support the thesis that a decrease in responsiveness to trophic hormones in ALD and AMN is secondary to changes in the membrane microviscosity of the target tissues and suggest a mechanism by which adrenal and gonadal failure occur in such patients.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6874949      PMCID: PMC1129179          DOI: 10.1172/jci110963

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  The relation between lipid mobility and the specific hormone binding of thyroid membranes.

Authors:  C L Bashford; S J Harrison; G K Radda
Journal:  Biochem J       Date:  1975-02       Impact factor: 3.857

2.  Adrenoleukodystrophy. A clinical and pathological study of 17 cases.

Authors:  H H Schaumburg; J M Powers; C S Raine; K Suzuki; E P Richardson
Journal:  Arch Neurol       Date:  1975-09

3.  Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects.

Authors:  J W Griffin; E Goren; H Schaumburg; W K Engel; L Loriaux
Journal:  Neurology       Date:  1977-12       Impact factor: 9.910

4.  Fatty acid abnormality in adrenoleukodystrophy.

Authors:  M Igarashi; H H Schaumburg; J Powers; Y Kishmoto; E Kolodny; K Suzuki
Journal:  J Neurochem       Date:  1976-04       Impact factor: 5.372

Review 5.  Abnormalities of cell-membrane fluidity in the pathogenesis of disease.

Authors:  R A Cooper
Journal:  N Engl J Med       Date:  1977-08-18       Impact factor: 91.245

6.  Fluorescent probe analysis of the lipid architecture of natural and experimental cholesterol-rich membranes.

Authors:  J Vanderkooi; S Fischkoff; B Chance; R A Cooper
Journal:  Biochemistry       Date:  1974-04-09       Impact factor: 3.162

7.  Microviscosity and order in the hydrocarbon region of phospholipid and phospholipid-cholesterol dispersions determined with fluorescent probes.

Authors:  U Cogan; M Shinitzky; G Weber; T Nishida
Journal:  Biochemistry       Date:  1973-01-30       Impact factor: 3.162

8.  Microviscosity parameters and protein mobility in biological membranes.

Authors:  M Shinitzky; M Inbar
Journal:  Biochim Biophys Acta       Date:  1976-04-16

9.  Fluorescence depolarization studies of phase transitions and fluidity in phospholipid bilayers. 2 Two-component phosphatidylcholine liposomes.

Authors:  B R Lentz; Y Barenholz; T E Thompson
Journal:  Biochemistry       Date:  1976-10-05       Impact factor: 3.162

10.  Adrenoleukodystrophy. Accumulation of cholesterol esters with very long chain fatty acids.

Authors:  J H Menkes; L M Corbo
Journal:  Neurology       Date:  1977-10       Impact factor: 9.910

View more
  27 in total

1.  ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.

Authors:  Mauhamad Baarine; Craig Beeson; Avtar Singh; Inderjit Singh
Journal:  J Neurochem       Date:  2015-01-13       Impact factor: 5.372

Review 2.  Evaluation of therapy of X-linked adrenoleukodystrophy.

Authors:  Hugo W Moser; Ali Fatemi; Kathleen Zackowski; Seth Smith; Xavier Golay; Larry Muenz; Gerald Raymond
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

Review 3.  Very long-chain fatty acids in diagnosis, pathogenesis, and therapy of peroxisomal disorders.

Authors:  H W Moser; A B Moser
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

4.  Effects of exogenous hexacosanoic acid on biochemical myelin composition in weaning and post-weaning rats.

Authors:  A Di Biase; C Avellino; F Pieroni; T Quaresima; A Grisolia; M Cappa; S Salvati
Journal:  Neurochem Res       Date:  1997-03       Impact factor: 3.996

Review 5.  The inborn errors of peroxisomal beta-oxidation: a review.

Authors:  R J Wanders; C W van Roermund; R B Schutgens; P G Barth; H S Heymans; H van den Bosch; J M Tager
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 6.  Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis.

Authors:  Inderjit Singh; Aurora Pujol
Journal:  Brain Pathol       Date:  2010-07       Impact factor: 6.508

7.  Thrombocytopenia induced by erucic acid therapy in patients with X-linked adrenoleukodystrophy.

Authors:  S Zierz; R Schröder; C J Unkrig
Journal:  Clin Investig       Date:  1993-10

Review 8.  Adrenoleukodystrophy: phenotypic variability and implications for therapy.

Authors:  H W Moser; A B Moser; K D Smith; A Bergin; J Borel; J Shankroff; O C Stine; C Merette; J Ott; W Krivit
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

9.  The Roles of β-Oxidation and Cofactor Homeostasis in Peroxisome Distribution and Function in Arabidopsis thaliana.

Authors:  Mauro A Rinaldi; Ashish B Patel; Jaeseok Park; Koeun Lee; Lucia C Strader; Bonnie Bartel
Journal:  Genetics       Date:  2016-09-07       Impact factor: 4.562

10.  Alterations of fatty acid metabolism and membrane fluidity in peroxisome-defective mutant ZP102 cells.

Authors:  Michiaki Nagura; Makiko Saito; Masao Iwamori; Yoichi Sakakihara; Takashi Igarashi
Journal:  Lipids       Date:  2004-01       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.